NCT03134014 is a NA clinical trial of Breakfast in Breakfast, sponsored by Purdue University.

Who is sponsoring NCT03134014?

NCT03134014 is sponsored by Purdue University.

What drugs are being tested in NCT03134014?

Interventions in NCT03134014: Breakfast.

What condition does NCT03134014 study?

NCT03134014 studies Breakfast, Appetitive Behavior.

Is NCT03134014 still recruiting?

NCT03134014 is currently completed. Last updated 2 May 2019.

Last reviewed 2019-05-02 · How we verify

NCT03134014

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

High Protein Breakfast on Weight Management and Glycemic Control in 'Breakfast-skipping' Teens

Completed NA Last updated 2 May 2019

What this trial tests

NA trial testing Breakfast in Breakfast in 26 participants. Completed in 11 May 2018.

Timeline

12 December 2016

Primary endpoint
11 May 2018

11 May 2018

Quick facts

Lead sponsor	Purdue University
Phase	NA
Status	Completed
Study type	INTERVENTIONAL
Allocation	randomized
Design	parallel
Masking	single
Primary purpose	other
Enrollment	26
Start date	12 December 2016
Primary completion	11 May 2018
Estimated completion	11 May 2018
Sites	1 location across United States

Drugs / interventions tested

Breakfast

Conditions studied

Breakfast — all drugs for Breakfast →
Appetitive Behavior — all drugs for Appetitive Behavior →

Sponsor

Purdue University

Who can join

Adults 15 to 21, any sex, with Breakfast or Appetitive Behavior. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

75 overweight, habitual 'breakfast-skipping' adolescents will complete the following long-term, randomized controlled trial. Participants will be randomly assigned to the following breakfast treatments: 350 kcal high protein breakfasts containing 30 g protein (primarily from lean beef), 35 g carbohydrates, and 10 g fat; 350 kcal normal protein breakfasts containing 10 g protein, 55 g carbohydrates, and 10 g fat; or will continue to skip breakfast. The following outcomes will be assessed during baseline and 4-month (post-intervention): body weight \& body composition; waist circumference; daily food intake; 24-h free-living glycemic control; and pre and post-prandial satiety. In addition, body weight and free-living breakfast intake (quantity, quality, and type) will also be assessed at 2-month follow-up

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

Effect of breakfast on weight and energy intake: systematic review and meta-analysis of randomised controlled trials.
Sievert K, Hussain SM, Page MJ, Wang Y, et al · · 2019 · cited 109× · PMID 30700403 · DOI 10.1136/bmj.l42

Verify or expand the search:

Other trials of Breakfast

Trials testing the same drug.

NCT06821620 — Interaction of MTNR1B Genotype and Type of Breakfast (Protein-enriched v Carbohydrate-rich) on Postprandial Glucose Resp · NA · completed
NCT05986097 — The Breakfast Study · Phase 1, PHASE2 · completed
NCT05414474 — Effects of Enhancers and Inhibitors on Absorption From Iron Supplements · NA · completed
NCT06546657 — Glucose Variability in Type 1 Diabetes (T1D) and Glycaemic Responses to Food Composition. · completed
NCT03146442 — Increased Protein at Breakfast for Weight Management in Overweight Adolescents · NA · completed

Other Purdue University trials

Trials by the same sponsor.

NCT07287774 — Evaluating a Deep Neural Noise-Reduction Algorithm for Hearing Aids · NA · recruiting
NCT07086833 — The Food Environment, Microbial Cysteine Metabolism, and Cancer Disparities · NA · recruiting
NCT06638944 — Wearable Biofeedback for Swallowing Disorders Rehabilitation in Stroke and Parkinson Disease · Phase 2 · recruiting
NCT07048392 — Retrieval-Based Word Learning in Developmental Language Disorder During Book Reading II · NA · recruiting
NCT06258941 — Classroom Break, Cognition, and Fitness in Elementary School Children · Phase 1, PHASE2 · recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT03134014 (US National Library of Medicine, public domain)
Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Purdue University
Last refreshed: 2 May 2019

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03134014.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing